Unknown

Dataset Information

The role of NT-proBNP in screening for atrial fibrillation in hypertensive disease.


ABSTRACT:

Background

Atrial fibrillation (AF) screening should be considered in elderly patients with high risk of stroke, which include individuals with hypertension. The biomarker N-terminal prohormone of brain natriuretic peptide (NT-proBNP) can predict incident AF and is increased in hypertensive individuals. The aim of this study is to investigate the incidence of screening-detected AF in elderly individuals in relation to NT-proBNP and hypertension.

Methods

STROKESTOP II is a randomized controlled trial in which 75/76-years-old individuals were invited to a screening study for AF using NT-proBNP as a discriminator of high risk. In this sub-study, a prior hypertension diagnosis was self-reported by participants and measured blood pressure was stratified into hypertension-grades.

SUBMITTER: Sado G 

PROVIDER: S-EPMC11795693 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature